ClinicalTrials.gg
CompletedNCT07783451Updated Aug 27, 2026

Effectiveness of Combining Patient Follow-Up With an Educational Intervention on Self-Management Skills of Type 2 Diabetes Mellitus Patients: A Controlled Intervention Study in Primary Care

An interventional study of A structured shared follow-up plan combined with patient education in Diabetes Mellitus Type 2, sponsored by Aysenur Aktemur. Completed at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-27.

Sponsored by Aysenur Aktemur · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Registered 5 years 3 months after the study started (first participant enrolled May 2021, registered Aug 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
84
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-14

Among 341 studies in Diabetes Mellitus, Type 2 with a site in Turkey — 62 open to participants now, 72 under way, 12 of them phase 3. Diabetes Mellitus, Type 2 · Turkey.

Enrollment
154th of 265
84 · median 100
Started
2021
with 33 others
No phase
149 of 341
34 open now
Registered
321st of 341
by date

Among the 341 studies in Diabetes Mellitus, Type 2 with a site in Turkey, this one is the 154th largest by enrollment of the 265 interventional ones that give a count, is one of 34 that started in 2021, is one of 149 with no phase, and was the 321st registered.

Diabetes Mellitus, Type 2

10,382 studies on the registry are indexed under Diabetes Mellitus, Type 2; 1,411 are open to participants now.

Browse Diabetes Mellitus, Type 2 studies →

Open to participants now

62 of the 341 studies in Diabetes Mellitus, Type 2 with a site in Turkey are open now. Recruiting first, the newest first:

57 more — sign in →

All 62 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 883 Diabetes Mellitus, Type 2 studies recruiting now, 374 (42%) set no upper age limit and 383 (43%) stop at 75 or younger; 52 take children under 18; 205 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Watch this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 341 studies in Diabetes Mellitus, Type 2 with a site in Turkey, or all of them as a file.
02

Study summary

The purpose of this clinical study is to evaluate whether patient education provided in conjunction with a structured, shared follow-up plan in primary care strengthens the self-management skills of patients with Type 2 Diabetes (T2DM). The study also aims to determine whether the effect of this intervention is associated with patients' baseline levels of health literacy.

The key questions this study aims to address are as follows:

  1. Do the structured follow-up model and educational intervention improve diabetes self-management skills (healthy lifestyle behaviors, blood glucose management, and use of health services) among patients with T2DM?
  2. Can this improvement in diabetes self-management skills occur regardless of patients' baseline levels of health literacy? To measure the effectiveness of structured follow-up in improving diabetes self-management, researchers will compare the intervention group-which receives in-person sessions supported by visual aids-with the control group, which is followed up via standard phone calls.

Participants will go through the following processes in the study:

Participants in the Intervention Group:

For three months, they will attend monthly in-person (or video-based, upon request) follow-up sessions with their family physicians. The first session lasts approximately 45 minutes, the second 20 minutes, and the third 15 minutes.

Together with their doctors, they will complete a "Diabetes (DM) ID Card" and receive education on diabetes care and monitoring for complications.

At home, they will monitor their own blood sugar levels, perform foot checks, and record this data in the "DM Diary" developed by the researchers.

At the clinic, they will undergo screenings for complications such as neuropathy, including foot examinations and the monofilament test, performed by their family physicians.

They will review changes in diet and physical activity with their physicians. At the start of the study and at the end of the third month, they will complete self-management and health literacy assessment scales.

Participants in the Control Group:

For three months, they will receive monthly phone calls from their family physicians lasting approximately 10 minutes, which will include general information about diabetes and reminders about complication screenings (eye, foot, and kidney examinations).

Participants will complete the diabetes self-management assessment scale at the start of the study and again at the end of the third month.

Read the detailed description

For use in the clinicaltrials.gov registration of this clinical trial, a comprehensive "Detailed Description" text-which does not contradict the "Brief Summary" section or repeat the information contained therein and which includes the technical and scientific background-has been prepared below:

  1. Scientific Rationale and Background The prevalence of diabetes is rapidly increasing worldwide; according to data from the International Diabetes Atlas 2025, an estimated 588.7 million people aged 20-79 have diabetes, and this number is expected to reach 822.5 million by 2050. The TURDEP-2 study conducted across Turkey also revealed a similar upward trend, showing that the prevalence of diabetes rose from 7.2% to 13.7% over a 12-year period (1998-2010). The long-term microvascular and macrovascular complications of diabetes constitute a significant disease burden; for example, diabetic nephropathy-the most common cause of end-stage renal disease in developed countries-develops in 20-40% of people with Type 2 Diabetes (T2DM) and increases the risk of cardiovascular mortality. Additionally, diabetic neuropathy-characterized by symmetrical loss of sensation-and peripheral vascular disease are the primary causes of foot ulcers and form the basis of diabetic foot cases, leading to approximately 12,000 amputations annually across Turkey.

    Primary care providers are responsible for regularly monitoring patients with diabetes, recommending screenings for complications, and educating patients on how to protect themselves from these complications. However, effective control of the disease requires patients to take responsibility for managing their own condition (self-management). Individuals with low health literacy (HL) have a higher risk of developing diabetes complications (particularly neurovascular complications and retinopathy), and these patients are less likely to have sufficient knowledge about diabetes care and self-care activities. According to data from the Turkey Health Literacy Survey, 24.5% of the population has inadequate health literacy, while 40.1% has problematic health literacy. Although there are many educational programs in the literature aimed at supporting diabetes self-management, the majority of these studies have been conducted in secondary or tertiary care facilities or specialized diabetes centers; however, access to such multidisciplinary expert teams is quite limited in communities with scarce resources. Therefore, there is a need for structured intervention models that can be implemented at the primary care level, aim to improve self-management skills even among patients with low health literacy, and are based on physician-patient collaboration.

  2. Study Design and Sample Size This study was designed as a pre-test/post-test comparative, non-randomized controlled clinical trial. The study was conducted at three different primary care centers in Istanbul. Instead of randomization, center-based grouping was chosen; patients registered at ASM-A formed the intervention group (IG), while those registered at ASM-B and ASM-C formed the control group (CG). This design was chosen to prevent patients at the same center from interacting with one another and sharing information (the contamination effect).

    The study's sample size was calculated using the Clinical Sample Size Calculator (ClinCalc) program, targeting a minimum increase of 8 points in self-management scale scores in the intervention group following the intervention, at a 95% confidence level and 80% power. Accordingly, with a 1:1 ratio, at least 40 participants were planned for each group, and the study was completed with a total of 84 patients.

  3. Theoretical Framework of the Intervention (Theoretical Framework of the Intervention) In educating patients with low health literacy, evidence-based strategies such as using simple language, focusing on direct actions, limiting the number of messages, taking cultural differences into account, supporting instructions with visual aids, and continuously monitoring the patient's level of understanding (teach-back method) have been adopted. Developed in line with these principles, the "Diabetes (DM) ID Card" and "DM Diary" have been visually enriched and prepared in extremely simple language to enable patients to manage their own self-care without being overwhelmed by complex medical information.

    Instead of conducting a traditional, one-way educational session, an interactive follow-up model was implemented in which the physician and patient engage in a two-way dialogue, and the patient actively shares their habits and the challenges they face. During this process, patients received in-person training from their physicians on how to perform daily blood glucose monitoring and self-examinations of their feet.

  4. Data Collection Tools and Scales (Measurement Instruments)

    Data from participants were collected using the following valid and reliable instruments administered by family physicians at the initial visit and at the end of the third month:

    Sociodemographic Questionnaire: A form prepared by the researchers that asks patients about their age, gender, education, income level, smoking and alcohol habits, and comorbidities.

    Hacettepe University Adult Health Literacy Scale Short Form (HU-SOÖ): A 24-item measure with two dimensions-Health Literacy and Self-Efficacy-and a Cronbach's alpha value of 0.84. The scale does not have a specific cut-off point; higher scores indicate a higher level of health literacy.

    Type 2 Diabetes Self-Management Scale (DÖYÖ): A 19-item scale using a 5-point Likert scale with a Cronbach's alpha value of 0.86. The scale consists of three subscales: "Healthy Lifestyle Behaviors," "Blood Sugar Management," and "Use of Health Services."

  5. Statistical Analysis Plan All data obtained in this study were analyzed using IBM SPSS version 23.0. Categorical variables were described using frequencies and percentages; the distribution of continuous variables was assessed using the Kolmogorov-Smirnov test and by examining kurtosis and skewness values. The chi-square and McNemar tests were used for categorical comparisons between groups. In the analysis of continuous variables, the paired t-test and independent samples t-test were used for data showing a normal distribution; for data not normally distributed, the Wilcoxon signed-rank test was preferred. Correlations between variables were calculated using Pearson or Spearman tests.

    An intent-to-treat (ITT) analysis was applied to control for the effect of patients who were lost to follow-up on the analysis. In this context, the post-test scores of 5 patients from each group who were unable to attend follow-up visits for various reasons (unreachability or death) were included in the analysis without assuming any change (while retaining their baseline scores).

  6. Ethical Approval and Permissions (Ethical Approvals) The ethical compliance of the study was approved by the Marmara University Faculty of Medicine Clinical Research Ethics Committee on May 7, 2021 (Protocol Code: 09.2021.601). Additionally, an official research permit (No. 2021/44) was obtained from the Istanbul Provincial Health Directorate on October 11, 2021.
03

Conditions studied

  • Diabetes Mellitus Type 2

Keywords

  • Self-Management
  • Patient-Empowerment
  • Primary Care
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must have a documented clinical diagnosis of Type 2 Diabetes Mellitus (T2DM).
  • Must be literate (able to read and write).
  • Must be able to monitor/measure blood glucose at home.

Exclusion criteria

Exclusion Criteria:

  • Inability to complete/apply the health literacy scale independently.
  • Currently receiving specialized diabetes care or treatment from a tertiary/specialized diabetes center.
  • Hospitalization due to diabetes-related complications during the course of the study.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
84 participants (actual)

Study arms

  • Experimental
    Intervention Group

    Behavioral: A structured shared follow-up plan combined with patient education

  • No intervention
    Control Group

Interventions

  • BehavioralA structured shared follow-up plan combined with patient education

    This intervention consists of a structured, patient-centered diabetes self-management program integrated into routine primary care, specifically designed to address low health literacy. Delivered face-to-face (or via video call) by family physicians over three monthly sessions of decreasing duration (approximately 45, 20, and 15 minutes, respectively). It utilizes low-literacy communication strategies, including plain language, action-focused messaging, visual aids, and the 'teach-back' method to confirm and reinforce understanding.

06

What researchers measure

Primary outcomes

  1. Change in Type 2 Diabetes Self-Management Scale (DSMS) Total Score

    The DSMS is a validated 19-item scale designed to assess diabetes self-management skills in patients with type 2 diabetes. It uses a 5-point Likert-type scoring system. The total score ranges from 19 to 95, with higher scores indicating a higher level of diabetes self-management skills. This outcome measure evaluates the change in total self-management skills from baseline to the end of the 3-month follow-up period.

    Time frame: Baseline and 3 months

07

Study locations

1 site
  • Marmara University Pendik Training and Research Hospital Tuzla Primary Health Center
    Istanbul, 34953, Turkey (Türkiye)
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from May 2021 to primary completion in Jan 2022, 8 months.

Of 2,068 non-industry interventional studies with no phase under Diabetes Mellitus, Type 2, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 40. This study's 8 months is below that.

Counting every sponsor, half of 2,245 studies reached it within 21 months; a quarter within 10 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 20, 2026
First posted
Aug 24, 2026
StartActual
May 1, 2021
Primary completionActual
Jan 30, 2022
CompletionActual
Jan 30, 2022
Last update
Aug 27, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07783451
Lead sponsor
Aysenur Aktemur
Responsible party
Aysenur Aktemur (Medicinae Doctor-Family Medicine Specialist, Marmara University) — Sponsor-investigator
First posted
Aug 24, 2026
Start date
May 1, 2021
Primary completion
Jan 30, 2022
Completion
Jan 30, 2022
Last update
Aug 27, 2026

Study contacts

Serap S Ciftcili, Prof. Dr.
principal investigator · Marmara University Faculty of Medicine, Department of Family Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion